These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22993428)

  • 21. Astroglial FMRP-dependent translational down-regulation of mGluR5 underlies glutamate transporter GLT1 dysregulation in the fragile X mouse.
    Higashimori H; Morel L; Huth J; Lindemann L; Dulla C; Taylor A; Freeman M; Yang Y
    Hum Mol Genet; 2013 May; 22(10):2041-54. PubMed ID: 23396537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors.
    Wang H; Wu LJ; Zhang F; Zhuo M
    J Neurosci; 2008 Apr; 28(17):4385-97. PubMed ID: 18434517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dephosphorylation-induced ubiquitination and degradation of FMRP in dendrites: a role in immediate early mGluR-stimulated translation.
    Nalavadi VC; Muddashetty RS; Gross C; Bassell GJ
    J Neurosci; 2012 Feb; 32(8):2582-7. PubMed ID: 22357842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FMRP-PKA Activity Negative Feedback Regulates RNA Binding-Dependent Fibrillation in Brain Learning and Memory Circuitry.
    Sears JC; Broadie K
    Cell Rep; 2020 Oct; 33(2):108266. PubMed ID: 33053340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
    Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
    Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S6K1 phosphorylates and regulates fragile X mental retardation protein (FMRP) with the neuronal protein synthesis-dependent mammalian target of rapamycin (mTOR) signaling cascade.
    Narayanan U; Nalavadi V; Nakamoto M; Thomas G; Ceman S; Bassell GJ; Warren ST
    J Biol Chem; 2008 Jul; 283(27):18478-82. PubMed ID: 18474609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression.
    Hou L; Antion MD; Hu D; Spencer CM; Paylor R; Klann E
    Neuron; 2006 Aug; 51(4):441-54. PubMed ID: 16908410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabotropic glutamate receptor activation regulates fragile x mental retardation protein and FMR1 mRNA localization differentially in dendrites and at synapses.
    Antar LN; Afroz R; Dictenberg JB; Carroll RC; Bassell GJ
    J Neurosci; 2004 Mar; 24(11):2648-55. PubMed ID: 15028757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reciprocal regulation of spontaneous synaptic vesicle fusion by Fragile X mental retardation protein and group I metabotropic glutamate receptors.
    Subrahmanyam R; Dwivedi D; Rashid Z; Bonnycastle K; Cousin MA; Chattarji S
    J Neurochem; 2021 Sep; 158(5):1094-1109. PubMed ID: 34327719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of FMRP and alterations of FMRP complex underlie enhanced mLTD in adult rats triggered by early life seizures.
    Bernard PB; Castano AM; O'Leary H; Simpson K; Browning MD; Benke TA
    Neurobiol Dis; 2013 Nov; 59():1-17. PubMed ID: 23831253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuron-Specific FMRP Roles in Experience-Dependent Remodeling of Olfactory Brain Innervation during an Early-Life Critical Period.
    Golovin RM; Vest J; Broadie K
    J Neurosci; 2021 Feb; 41(6):1218-1241. PubMed ID: 33402421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis.
    Auerbach BD; Bear MF
    J Neurophysiol; 2010 Aug; 104(2):1047-51. PubMed ID: 20554840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.
    Gross C; Chang CW; Kelly SM; Bhattacharya A; McBride SM; Danielson SW; Jiang MQ; Chan CB; Ye K; Gibson JR; Klann E; Jongens TA; Moberg KH; Huber KM; Bassell GJ
    Cell Rep; 2015 May; 11(5):727-36. PubMed ID: 25921541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragile X syndrome: From protein function to therapy.
    Bagni C; Oostra BA
    Am J Med Genet A; 2013 Nov; 161A(11):2809-21. PubMed ID: 24115651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.
    Nosyreva ED; Huber KM
    J Neurophysiol; 2006 May; 95(5):3291-5. PubMed ID: 16452252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanistic relationships between Drosophila fragile X mental retardation protein and metabotropic glutamate receptor A signaling.
    Pan L; Woodruff E; Liang P; Broadie K
    Mol Cell Neurosci; 2008 Apr; 37(4):747-60. PubMed ID: 18280750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model.
    Goebel-Goody SM; Wilson-Wallis ED; Royston S; Tagliatela SM; Naegele JR; Lombroso PJ
    Genes Brain Behav; 2012 Jul; 11(5):586-600. PubMed ID: 22405502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant RNA translation in fragile X syndrome: From FMRP mechanisms to emerging therapeutic strategies.
    Banerjee A; Ifrim MF; Valdez AN; Raj N; Bassell GJ
    Brain Res; 2018 Aug; 1693(Pt A):24-36. PubMed ID: 29653083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.